Modelizzazione spazio-temporale delle dinamiche di uso del suolo ed analisi comparativa di differenti approcci predittivi. Uso integrato di SIG e telerilevamento nello studio dei processi di deforestazione nella regione La Joyanca in Peten, Guatemala

L’uso frequente dei modelli predittivi per l’analisi di sistemi complessi, naturali o artificiali, sta cambiando il tradizionale approccio alle problematiche ambientali e di rischio. Il continuo miglioramento delle capacità di elaborazione dei computer facilita l’utilizzo e la risoluzione di metodi numerici basati su una discretizzazione spazio-temporale che permette una modellizzazione predittiva di sistemi reali complessi, riproducendo l’evoluzione dei loro patterns spaziali ed calcolando il grado di precisione della simulazione. In questa tesi presentiamo una applicazione di differenti metodi predittivi (Geomatico, Reti Neurali, Land Cover Modeler e Dinamica EGO) in un’area test del Petén, Guatemala. Durante gli ultimi decenni questa regione, inclusa nella Riserva di Biosfera Maya, ha conosciuto una rapida crescita demografica ed un’incontrollata pressione sulle sue risorse naturali. L’area test puó essere suddivisa in sotto-regioni caratterizzate da differenti dinamiche di uso del suolo. Comprendere e quantificare queste differenze permette una migliore approssimazione del sistema reale; é inoltre necessario integrare tutti i parametri fisici e socio-economici, per una rappresentazione più completa della complessità dell’impatto antropico. Data l’assenza di informazioni dettagliate sull’area di studio, quasi tutti i dati sono stati ricavati dall’elaborazione di 11 immagini ETM+, TM e SPOT; abbiamo poi realizzato un’analisi multitemporale dei cambi uso del suolo passati e costruito l’input per alimentare i modelli predittivi. I dati del 1998 e 2000 sono stati usati per la fase di calibrazione per simulare i cambiamenti nella copertura terrestre del 2003, scelta come data di riferimento per la validazione dei risultati. Quest’ultima permette di evidenziare le qualità ed i limiti per ogni modello nelle differenti sub-regioni.

Development of Clinical Decision Support Systems based on Mathematical Models of Physiological Systems

In the last years of research, I focused my studies on different physiological problems. Together with my supervisors, I developed/improved different mathematical models in order to create valid tools useful for a better understanding of important clinical issues. The aim of all this work is to develop tools for learning and understanding cardiac and cerebrovascular physiology as well as pathology, generating research questions and developing clinical decision support systems useful for intensive care unit patients. I. ICP-model Designed for Medical Education We developed a comprehensive cerebral blood flow and intracranial pressure model to simulate and study the complex interactions in cerebrovascular dynamics caused by multiple simultaneous alterations, including normal and abnormal functional states of auto-regulation of the brain. Individual published equations (derived from prior animal and human studies) were implemented into a comprehensive simulation program. Included in the normal physiological modelling was: intracranial pressure, cerebral blood flow, blood pressure, and carbon dioxide (CO2) partial pressure. We also added external and pathological perturbations, such as head up position and intracranial haemorrhage. The model performed clinically realistically given inputs of published traumatized patients, and cases encountered by clinicians. The pulsatile nature of the output graphics was easy for clinicians to interpret. The manoeuvres simulated include changes of basic physiological inputs (e.g. blood pressure, central venous pressure, CO2 tension, head up position, and respiratory effects on vascular pressures) as well as pathological inputs (e.g. acute intracranial bleeding, and obstruction of cerebrospinal outflow). Based on the results, we believe the model would be useful to teach complex relationships of brain haemodynamics and study clinical research questions such as the optimal head-up position, the effects of intracranial haemorrhage on cerebral haemodynamics, as well as the best CO2 concentration to reach the optimal compromise between intracranial pressure and perfusion. We believe this model would be useful for both beginners and advanced learners. It could be used by practicing clinicians to model individual patients (entering the effects of needed clinical manipulations, and then running the model to test for optimal combinations of therapeutic manoeuvres). II. A Heterogeneous Cerebrovascular Mathematical Model Cerebrovascular pathologies are extremely complex, due to the multitude of factors acting simultaneously on cerebral haemodynamics. In this work, the mathematical model of cerebral haemodynamics and intracranial pressure dynamics, described in the point I, is extended to account for heterogeneity in cerebral blood flow. The model includes the Circle of Willis, six regional districts independently regulated by autoregulation and CO2 reactivity, distal cortical anastomoses, venous circulation, the cerebrospinal fluid circulation, and the intracranial pressure-volume relationship. Results agree with data in the literature and highlight the existence of a monotonic relationship between transient hyperemic response and the autoregulation gain. During unilateral internal carotid artery stenosis, local blood flow regulation is progressively lost in the ipsilateral territory with the presence of a steal phenomenon, while the anterior communicating artery plays the major role to redistribute the available blood flow. Conversely, distal collateral circulation plays a major role during unilateral occlusion of the middle cerebral artery. In conclusion, the model is able to reproduce several different pathological conditions characterized by heterogeneity in cerebrovascular haemodynamics and can not only explain generalized results in terms of physiological mechanisms involved, but also, by individualizing parameters, may represent a valuable tool to help with difficult clinical decisions. III. Effect of Cushing Response on Systemic Arterial Pressure. During cerebral hypoxic conditions, the sympathetic system causes an increase in arterial pressure (Cushing response), creating a link between the cerebral and the systemic circulation. This work investigates the complex relationships among cerebrovascular dynamics, intracranial pressure, Cushing response, and short-term systemic regulation, during plateau waves, by means of an original mathematical model. The model incorporates the pulsating heart, the pulmonary circulation and the systemic circulation, with an accurate description of the cerebral circulation and the intracranial pressure dynamics (same model as in the first paragraph). Various regulatory mechanisms are included: cerebral autoregulation, local blood flow control by oxygen (O2) and/or CO2 changes, sympathetic and vagal regulation of cardiovascular parameters by several reflex mechanisms (chemoreceptors, lung-stretch receptors, baroreceptors). The Cushing response has been described assuming a dramatic increase in sympathetic activity to vessels during a fall in brain O2 delivery. With this assumption, the model is able to simulate the cardiovascular effects experimentally observed when intracranial pressure is artificially elevated and maintained at constant level (arterial pressure increase and bradicardia). According to the model, these effects arise from the interaction between the Cushing response and the baroreflex response (secondary to arterial pressure increase). Then, patients with severe head injury have been simulated by reducing intracranial compliance and cerebrospinal fluid reabsorption. With these changes, oscillations with plateau waves developed. In these conditions, model results indicate that the Cushing response may have both positive effects, reducing the duration of the plateau phase via an increase in cerebral perfusion pressure, and negative effects, increasing the intracranial pressure plateau level, with a risk of greater compression of the cerebral vessels. This model may be of value to assist clinicians in finding the balance between clinical benefits of the Cushing response and its shortcomings. IV. Comprehensive Cardiopulmonary Simulation Model for the Analysis of Hypercapnic Respiratory Failure We developed a new comprehensive cardiopulmonary model that takes into account the mutual interactions between the cardiovascular and the respiratory systems along with their short-term regulatory mechanisms. The model includes the heart, systemic and pulmonary circulations, lung mechanics, gas exchange and transport equations, and cardio-ventilatory control. Results show good agreement with published patient data in case of normoxic and hyperoxic hypercapnia simulations. In particular, simulations predict a moderate increase in mean systemic arterial pressure and heart rate, with almost no change in cardiac output, paralleled by a relevant increase in minute ventilation, tidal volume and respiratory rate. The model can represent a valid tool for clinical practice and medical research, providing an alternative way to experience-based clinical decisions. In conclusion, models are not only capable of summarizing current knowledge, but also identifying missing knowledge. In the former case they can serve as training aids for teaching the operation of complex systems, especially if the model can be used to demonstrate the outcome of experiments. In the latter case they generate experiments to be performed to gather the missing data.

Entwicklung molekularbiologischer Methoden zum Nachweis verschiedener Sclerotiniaceae

Botrytis cinerea ist einer der wichtigsten Phytopathogene, der im Bereich der Weinbereitung als Erreger des Edel- bzw. des Grauschimmels von Trauben eine zentrale Stellung einnimmt. Taxonomisch gehört dieser Organismus zur Familie der Sclerotiniaceae, die ausnahmslos Phytopathogene sind und weltweit große Schäden bei verschiedenen Pflanzen verursachen. Die molekularbiologische Identifikation von Vertretern dieser wichtigen Gruppe von Pflanzenpathogenen ist jedoch bis heute ein Problem. Aus diesem Grund wurde in der vorliegenden Arbeit als Themenschwerpunkt die zweifelsfreie Identifikation einiger Vertreter der Sclerotiniaceae bearbeitet. Hier konnte von neun verschiedenen Organismen die ‚Internal Transcribed Spacer Region’ identifiziert und zusätzlich zur 18S rDNA für eine sichere Identifikation ausgeschlossen werden. Die Unterscheidung der einzelnen Gattungen und verschiedener B. cinerea-Stämme wurde mit Hilfe der neuartigen nSAPD-PCR Technologie erfolgreich überprüft. Hier konnten die drei Gattungen Botrytis, Monilinia sowie Sclerotinia zweifelsfrei differenziert werden. Ferner konnten von Monilinia fructigena, Sclerotinia minor und Sclerotinia sclerotiorum neue Laccase-Gene identifiziert und komplett sequenziert werden, die homolog zur Laccase2 (lcc2) von B. cinerea sind. Auf Basis dieser Sequenzen bzw. Sequenzunterschiede konnte eine Multiplex-PCR zur zweifelsfreien Identifi-kation dieser Spezies etabliert werden. Im Folgenden konnte dieses System auch an Umweltproben aus der Umgebung von Mainz und Wiesbaden, aus Flomborn (Rheinhessen) sowie aus Stollberg (Sachsen) überprüft werden. Anhand dieser Proben konnte gleichzeitig ein konstantes Vorkommen dieses Gens in allen über-prüften Organismen gezeigt werden. Somit ist es zum ersten Mal möglich, ver-schiedene Spezies der Sclerotiniaceae in einer Probe simultan nachzuweisen und zu differenzieren. Anschließend wurde die Laccase-Expression der jeweiligen Sclerotiniaceae überprüft. Für M. fructigena konnte mindestens eine konstitutiv exprimierte Laccase im Kulturüberstand detektiert werden. Im Gegensatz dazu zeigten weder S. minor noch S. sclerotiorum eine derartige Aktivität. Da B. cinerea lcc2 expri-miert, wurde dies auch für M. fructigena angenommen. Die reverse Transkription der codierenden mRNA konnte jedoch nicht erfolgreich durchgeführt werden. Die Analyse des Genoms von B. cinerea und S. sclerotiorum zeigte zudem 13 bzw. 8 mögliche Laccase-Gene. Somit ist es wahrscheinlich, dass M. fructigena mehr als einen codierenden Bereich für ein derartiges Enzym besitzt und somit eine oder mehrere andere Laccasen exprimiert. Auf Basis der codierenden DNA-Sequenzen konnten EDV-gestützte Prote-incharakterisierungen mit allen neu entdeckten Laccase-Sequenzen durchgeführt werden. Die hier ermittelten Eigenschaften legen den Schluss nahe, dass es sich ausnahmslos um Proteine handelt, die extrazellulär lokalisiert sind. So besitzen alle drei eine identisch lange Signalsequenz, die für die Translokation in die extra-zelluläre Matrix nötig ist. Des Weiteren zeigen alle Laccasen eine schwache Hydrophobizität, so dass davon ausgegangen werden kann, dass diese Enzyme keine membranständigen Proteine sind. Auch konnten zahlreiche Glykosylie-rungspositionen ermittelt werden und bei M. fructigena die Glykosylierung der akti-ven Laccase nachgewiesen werden. Des Weiteren konnten alle konservierten Kupferbindepositionen ermittelt werden. Der Vergleich zur mRNA der Lcc2 von B. cinerea offenbarte die lcc2 von M. fructigena drei nicht-codierende Intronse-quenzen, für S. minor und S. sclerotiorum jedoch lediglich die ersten beiden. Somit bleibt für alle neu identifizierten Sequenzen die Frage nach der Expression offen. Es wurden weder Deletionen von Nukleotiden noch frame-shift Mutationen in den einzelnen Genen gefunden. Auch geben die Signalsequenzen bzw. die ent-haltenen Kupferbindepositionen keine Aufschluss über das Ausbleiben der Ex-pression dieser Gene. Da das von B. cinerea synthetisierte ß-1,3-1,6-Glucan in der Kellerwirtschaft große Filtrationsprobleme verursacht, wurde als ein zusätzlicher Themenschwerpunkt die Lyse dieses Polymers mit symbiontischen Mikroorganismen aus Termitendär-men untersucht. Da Termiten auf den Abbau von Polymeren, wie Cellulose und Hemicellulosen spezialisiert sind, lag die Vermutung nahe, dass auch das ß-Glucan von symbiontischen Mikroorganismen hydrolysiert werden kann. In der hier vorliegenden Arbeit konnte zwar das ß-Glucan erfolgreich herge-stellt und in pulverisierter Form 5 verschiedenen Termitenspezies als Futter ange-boten werden, die anschließende Isolierung der Darmflora und die Untersuchung der isolierten Mikroorganismen auf ein mögliche glucanolytische Aktivität erbrach-te jedoch nicht den erhofften Erfolg. Hier wurden acht verschiedene filamentöse Ascomyceten bzw. Zygomyceten isoliert, eine lytische Aktivität konnte jedoch bei keiner dieser Spezies gezeigt werden.

Cell-free cryopreserved arterial allografts from multiorgan donors: a new strategy to fabricate artificial blood vessels suited for peripheral vascular surgery

Critical lower limb ischemia is a severe disease. A common approach is infrainguinal bypass. Synthetic vascular prosthesis, are good conduits in high-flow low-resistance conditions but have difficulty in their performance as small diameter vessel grafts. A new approach is the use of native decellularized vascular tissues. Cell-free vessels are expected to have improved biocompatibility when compared to synthetic and are optimal natural 3D matrix templates for driving stem cell growth and tissue assembly in vivo. Decellularization of tissues represent a promising field for regenerative medicine, with the aim to develop a methodology to obtain small-diameter allografts to be used as a natural scaffold suited for in vivo cell growth and pseudo-tissue assembly, eliminating failure caused from immune response activation. Material and methods. Umbilical cord-derived mesenchymal cells isolated from human umbilical cord tissue were expanded in advanced DMEM. Immunofluorescence and molecular characterization revealed a stem cell profile. A non-enzymatic protocol, that associate hypotonic shock and low-concentration ionic detergent, was used to decellularize vessel segments. Cells were seeded cell-free scaffolds using a compound of fibrin and thrombin and incubated in DMEM, after 4 days of static culture they were placed for 2 weeks in a flow-bioreactor, mimicking the cardiovascular pulsatile flow. After dynamic culture, samples were processed for histological, biochemical and ultrastructural analysis. Discussion. Histology showed that the dynamic culture cells initiate to penetrate the extracellular matrix scaffold and to produce components of the ECM, as collagen fibres. Sirius Red staining showed layers of immature collagen type III and ultrastructural analysis revealed 30 nm thick collagen fibres, presumably corresponding to the immature collagen. These data confirm the ability of cord-derived cells to adhere and penetrate a natural decellularized tissue and to start to assembly into new tissue. This achievement makes natural 3D matrix templates prospectively valuable candidates for clinical bypass procedures

Rolle der gemeinsamen Expression von AML1-ETO und weiteren Onkogenen für die Induktion von Leukämie

Akute Leukämien treten in allen Altersstufen auf. Akute lymphatische Leukämie (ALL) ist die häufigste Leukämie bei Kindern, während akute myeloischen Leukämien (AML) mit verschiedenen Untergruppen etwa 80% aller akuten Leukämien bei Erwachsenen ausmachen. Die Translokation t(8;21) resultiert in der Entstehung des Fusionsgens AML1-ETO und zählt zu den häufigen Translokationen bei der AML. Dabei fusioniert die DNA-bindende Domäne des AML1 mit dem fast kompletten ETO-Protein. AML1-ETO wirkt als dominanter Repressor der AML1-vermittelten transkriptionellen Regula-tion wichtiger hämatopoetischer Zielgene. Klinische Daten legen nahe, dass trotz der klarer Assoziation zwischen AML und der t(8;21) Translokation bei AML Patienten zusätzliche genetische Veränderungen – so genannte ‚second hits‘ – notwendig sind, um eine Leukämie effizient zu induzieren. Klinisch relevanten Komplimentationsonkogene sind unter anderen die aktivierte Rezeptortyrosinkinase FLT3, JAK2, NRAS, KRAS, c- KIT.rnZiel der vorliegenden Arbeit war es, ein Mausmodell zu etablieren, welches humane akute myeloische Leukämie rekapituliert und bei dem die Expression der entsprechen-den Onkogene reguliert werden kann. Als erstes wurde untersucht, ob eine gemeinsame Expression von AML1-ETO mit kRASG12D zur Induktion von Leukämie führen kann. Hierfür wurden Tiere generiert die gemeinsam AML1-ETO und kRASG12D unter der regulatorischen Sequenz des Tetrazyklin-Operators exprimierten. Der große Vorteil dieser Technologie ist die regulierbare Reversibilität der Genexpression. Um die Ex-pression der Zielgene auf blutbildende Zellen zu beschränken, wurden Knochenmark-chimären hergestellt. Im Beobachtungszeitraum von 12 Monaten führte die Expression von AML1-ETO und AML1-ETO/kRASG12D nicht zur Induktion einer akuten Leukä-mie. Die normale hämatopoetische Entwicklung war jedoch in diesen Tieren gestört. Der beobachtete Phänotyp entsprach einem myelodysplastischen Syndrome (MDS).rnIm zweiten Ansatz, wurden Tiere generiert die gemeinsam AML1-ETO und FLT3-ITD exprimierten. Hierfür wurden hämatopoetische Stammzellen aus ROSA26-iM2/tetO-AML1-ETO isoliert und mit Hilfe des retroviralen Vektors mit FLT3-ITD transduziert. In diesem Modell war es möglich, in kurzer Zeit eine akute Leukämie mit zu induzieren. Einige wenige Tiere hatten zum Zeitpunkt des Todes Anzeichen einer biphänotypischen Leukämie mit lymphatischen und myeloischen Blastenpopulationen. In drei Tieren in-duzierte die alleinige Expression von FLT3-ITD eine Leukämie. Alle Leukämien wurden durch FACS, Zytologie und Histopathologie bestätigt. Knochenmark- bzw. Milzzellen aus den erkrankten Tieren waren in der Lage nach Transfer in sekundäre Rezipienten eine Leukämie auszulösen. Somit besaßen sie ein uneingeschränktes Selbsterneue-rungspotential.rnEin erster Versuch, in dem AML1-ETO Expression in leukämischen Zellen abgeschaltet und FLT3-ITD mit Tyrosinkinase-Inhibitor inhibiert wurde, zeigte keine wesentliche Veränderung in der Leukämieprogression.rnDieses Leukämiemodell erlaubt die Rolle der beteiligten Onkogene während verschie-dener Stadien der Leukämie zu erforschen und damit möglicherweise neue Ansätze für Therapiestrategien zu entwickeln.

Realizzazione di un simulatore biomeccanico del sistema ventricolo-aorta e studio della contropulsazione passiva

La sinergia tra diverse aree scientifiche svolge oggi un ruolo preminente nella risoluzione di problematiche molto complesse: in ambito medico, un massiccio intervento delle scienze fisico-matematiche ha portato, grazie alla ricerca sulle proprietà subatomiche (NMR), sulla funzione elettromeccanica tissutale (pace-makers) e sulla biocompatibilità di materiali innovativi, ad un completo rinnovamento e miglioramento delle terapie tradizionali, delineando nuove strategie terapeutiche. In questo quadro di attiva collaborazione si colloca la ricerca in ambito biomeccanico cardiovascolare che, approfondendo la funzionalità del cuore e dei vasi in condizioni normali e patologiche, propone soluzioni terapeutiche alternative all'approccio farmacologico, impensabili fino a pochi anni fa. Uno di questi ambiti è l'insufficienza cardiaca: al ventricolo incapace di produrre l'energia necessaria alla perfusione ematica viene associato un sistema di pulsazione meccanica che riduce il carico durante l'eiezione ed aumenta la perfusione coronarica in diastole. Tuttavia, benché l'efficacia della contropulsazione intra-aortica sia riconosciuta da decenni, alcune problematiche rimangono irrisolte: l'inapplicabilità su pazienti aritmici, l'eccessiva sollecitazione meccanica in pazienti vasculopatici, la complessità e l'alto costo dell'apparecchiatura. Questo lavoro affronta la validazione e la caratterizzazione di una soluzione terapeutica alternativa, di tipo completamente passivo, il cui effetto non è basato sulla somministrazione di energia meccanica dall'esterno, attraverso la pulsazione, ma sull'adattamento di impedenza biomeccanica tra la sorgente elastica pulsatile (il ventricolo) ed il carico (l'aorta). Per verificare l'ipotesi funzionale è stato realizzato un sistema contrattile che simulasse diversi livelli di insufficienza ventricolare ed un sistema vascolare con resistenza idraulica ed elastanza variabili. Sono stati rilevati i parametri fisiologici (pressioni, flusso, potenza ed efficienza) nelle diverse condizioni di accoppiamento biomeccanico e si sono ripetuti i rilievi inserendo il dispositivo di contropulsazione passiva. La validazione sperimentale ha prodotto risultati coerenti con quanto atteso ed è stata indispensabile per l'ottenimento, da parte del Comitato Etico, dell'autorizzazione per la sperimentazione clinica del sistema in oggetto.

Effect of pulsatility on the mathematical modeling of rotary blood pumps

In this study, the effect of time derivatives of flow rate and rotational speed was investigated on the mathematical modeling of a rotary blood pump (RBP). The basic model estimates the pressure head of the pump as a dependent variable using measured flow and speed as predictive variables. Performance of the model was evaluated by adding time derivative terms for flow and speed. First, to create a realistic working condition, the Levitronix CentriMag RBP was implanted in a sheep. All parameters from the model were physically measured and digitally acquired over a wide range of conditions, including pulsatile speed. Second, a statistical analysis of the different variables (flow, speed, and their time derivatives) based on multiple regression analysis was performed to determine the significant variables for pressure head estimation. Finally, different mathematical models were used to show the effect of time derivative terms on the performance of the models. In order to evaluate how well the estimated pressure head using different models fits the measured pressure head, root mean square error and correlation coefficient were used. The results indicate that inclusion of time derivatives of flow and speed can improve model accuracy, but only minimally.

Aortic flow patterns resulting from right axillary artery cannulation

Right axillary artery (RAA) cannulation is increasingly used in cardiac surgery. Little is known about resulting flow patterns in the aorta. Therefore, flow was visualized and analyzed. A mock circulatory circuit was assembled based on a compliant transparent anatomical silicon aortic model. A RAA cannula was connected to a continuous flow rotary blood pump (RBP), pulsatile heart action was provided by a pneumatic ventricular assist device (PVAD). Peripheral vascular resistance, regional flow and vascular compliance were adjusted to obtain physiological flow and pressure waveforms. Colorants were injected automatically for flow visualization. Five flow distributions with a total flow of 4 l/min were tested (%PVAD:%RBP): 100:0, 75:25, 50:50, 25:75, 0:100. Colorant distribution was assessed using quantitative 2D image processing. Continuous flow from the RAA divided in a retrograde and an antegrade portion. Retro- to antegrade flow ratio increased with increasing RAA-flow. At full RBP support flow was stagnant in the ascending aorta. There were distinct flow patterns between the right- and left-sided supra-aortic branches. At full RBP support retrograde flow was demonstrated in the right carotid and right vertebral arteries. Further studies are needed to confirm and evaluate the described flow patterns.

A simple, economical, and effective portable paediatric mock circulatory system

Ventricular assist devices (VADs) and total artificial hearts have been in development for the last 50 years. Since their inception, simulators of the circulation with different degrees of complexity have been produced to test these devices in vitro. Currently, a new path has been taken with the extensive efforts to develop paediatric VADs, which require totally different design constraints. This paper presents the manufacturing details of an economical simulator of the systemic paediatric circulation. This simulator allows the insertion of a paediatric VAD, includes a pumping ventricle, and is adjustable within the paediatric range. Rather than focusing on complexity and physiological simulation, this simulator is designed to be simple and practical for rapid device testing. The simulator was instrumented with medical sensors and data were acquired under different conditions with and without the new PediaFlowTM paediatric VAD. The VAD was run at different impeller speeds while simulator settings such as vascular resistance and stroke volume were varied. The hydraulic performance of the VAD under pulsatile conditions could be characterized and the magnetic suspension could be tested via manipulations such as cannula clamping. This compact mock loop has proven to be valuable throughout the PediaFlow development process and has the advantage that it is uncomplicated and can be manufactured cheaply. It can be produced by several research groups and the results of different VADs can then be compared easily.

Continuous flow left ventricular assist devices: a valid option for heart failure patients

Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to additional strategies in the treatment of end stage heart failure (HF). Heart transplantation (HTx) can be postponed and for certain patients even replaced by smaller implantable left ventricular assist devices (LVAD). Mechanical support of the failing left ventricle enables appropriate hemodynamic stabilisation and recovery of secondary organ failure, often seen in these severely ill patients. These new devices may be of great help to bridge patients until a suitable cardiac allograft is available but are also discussed as definitive treatment for patients who do not qualify for transplantation. Main indications for LVAD implantation are bridge to recovery, bridge to transplantation or destination therapy. LVAD may be an important tool for patients with an expected prolonged period on the waiting list, for instance those with blood group 0 or B, with a body weight over 90 kg and those with potentially reversible secondary organ failure and pulmonary artery hypertension. However, LVAD implantation means an additional heart operation with inherent peri-operative risks and complications during the waiting period. Finally, cardiac transplantation in patients with prior implantation of a LVAD represents a surgical challenge. This review summarises the current knowledge about LVAD and continuous flow devices especially since the latter have been increasingly used worldwide in the most recent years. The review is also based on the institutional experience at Berne University Hospital between 2000 and 2012. Apart from short-term devices (Impella, Cardiac Assist, Deltastream and ECMO) which were used in approximately 150 cases, 85 pulsatile long-term LVAD, RVAD or bi-VAD and 44 non-pulsatile LVAD (mainly HeartMateII and HeartWare) were implanted. After an initial learning curve, one-year mortality dropped to 10.4% in the last 58 patients.

Control of ventricular unloading using an electrocardiogram-synchronized Thoratec paracorporeal ventricular assist device

OBJECTIVE: Current pulsatile ventricular assist devices operate asynchronous with the left ventricle in fixed-rate or fill-to-empty modes because electrocardiogram-triggered modes have been abandoned. We hypothesize that varying the ejection delay in the synchronized mode yields more precise control of hemodynamics and left ventricular loading. This allows for a refined management that may be clinically beneficial. METHODS: Eight sheep received a Thoratec paracorporeal ventricular assist device (Thoratec Corp, Pleasanton, Calif) via ventriculo-aortic cannulation. Left ventricular pressure and volume, aortic pressure, pulmonary flow, pump chamber pressure, and pump inflow and outflow were recorded. The pump was driven by a clinical pneumatic drive unit (Medos Medizintechnik AG, Stolberg, Germany) synchronously with the native R-wave. The start of pump ejection was delayed between 0% and 100% of the cardiac period in 10% increments. For each of these delays, hemodynamic variables were compared with baseline data using paired t tests. RESULTS: The location of the minimum of stroke work was observed at a delay of 10% (soon after aortic valve opening), resulting in a median of 43% reduction in stroke work compared with baseline. Maximum stroke work occurred at a median delay of 70% with a median stroke work increase of 11% above baseline. Left ventricular volume unloading expressed by end-diastolic volume was most pronounced for copulsation (delay 0%). CONCLUSIONS: The timing of pump ejection in synchronized mode yields control over left ventricular energetics and can be a method to achieve gradual reloading of a recoverable left ventricle. The traditionally suggested counterpulsation is not optimal in ventriculo-aortic cannulation when maximum unloading is desired.

[Improve your skills!: evaluation of a 2.5-day basic course in vascular surgery for surgical trainees]

The traditional surgical training in the operating room (OR) is often complemented by participation in workshops and on simulators. The foundation Vascular International offers basic courses for vascular surgery techniques with training on pulsatile circulation, lifelike anatomical models. The aim of this study was to assess the efficacy of a 2.5-day intensive course on basic skills in vascular surgery.

In vitro hemodynamic evaluation of ventricular suction conditions of the EVAHEART ventricular assist pump

Purpose: Mismatches between pump output and venous return in a continuous-flow ventricular assist device may elicit episodes of ventricular suction. This research describes a series of in vitro experiments to characterize the operating conditions under which the EVAHEART centrifugal blood pump (Sun Medical Technology Research Corp., Nagano, Japan) can be operated with minimal concern regarding left ventricular (LV) suction. Methods: The pump was interposed into a pneumatically driven pulsatile mock circulatory system (MCS) in the ventricular apex to aorta configuration. Under varying conditions of preload, afterload, and systolic pressure, the speed of the pump was increased step-wise until suction was observed. Identification of suction was based on pump inlet pressure. Results: In the case of reduced LV systolic pressure, reduced preload (=10 mmHg), and afterload (=60 mmHg), suction was observed for speeds =2,200 rpm. However, suction did not occur at any speed (up to a maximum speed of 2,400 rpm) when preload was kept within 10-14 mmHg and afterload =80 mmHg. Although in vitro experiments cannot replace in vivo models, the results indicated that ventricular suction can be avoided if sufficient preload and afterload are maintained. Conclusion: Conditions of hypovolemia and/or hypotension may increase the risk of suction at the highest speeds, irrespective of the native ventricular systolic pressure. However, in vitro guidelines are not directly transferrable to the clinical situation; therefore, patient-specific evaluation is recommended, which can be aided by ultrasonography at various points in the course of support.

Vertebral artery dissection: presenting findings and predictors of outcome

BACKGROUND AND PURPOSE: Few data exist about clinical, radiologic findings, clinical outcome, and its predictors in patients with spontaneous vertebral artery dissection (sVAD). METHODS: Clinical characteristics, imaging findings, 3-month outcomes, and its predictors were investigated in consecutive patients with sVAD. RESULTS: One hundred sixty-nine patients with 195 sVAD were identified. Brain ischemia occurred in 131 patients (77%; ischemic stroke, n=114, 67%; transient ischemic attack, n=17, 10%). Three patients with ischemic stroke showed also signs of subarachnoid hemorrhage (SAH); 3 (2%) had SAH without ischemia. The 134 patients with brain ischemia or SAH had head and/or neck pain in 118 (88%) and pulsatile tinnitus in seven (5%) patients. The remaining 35 patients (21%) had isolated head and/or neck pain in 21 (12%) cases, asymptomatic sVAD in 13 (8%), and cervical radiculopathy in one case (1%). Location of sVAD was more often in the pars transversaria (V2; 35%) or atlas loop (V3; 34%) than in the prevertebral (V1; 20%) or intracranial (V4; 11%) segment (P=0.0001). Outcome was favorable (modified Rankin scale score 0 or 1) in 88 (82%) of 107 ischemic stroke patients with follow up. Two (2%) patients died. Low baseline National Institutes of Health Stroke Scale score (P<0.0001) and younger age (P=0.007) were independent predictors of favorable outcome. CONCLUSIONS: sVAD is predominantly located in the pars transversaria (V2) or the atlas loop (V3). Most patients show posterior circulation ischemia. Favorable outcome is observed in most ischemic strokes and independently predicted by low National Institutes of Health Stroke Scale score and younger age.

[What is the value of determining immunoreactive GHRH in acromegaly?]

Acromegaly is usually due to autonomous, excessive secretion of growth hormone from a pituitary adenoma. One would expect growth hormone-releasing factor (GHRH) in these patients to be suppressed. In the available literature referring to acromegaly, immunoreactive GHRH levels were determined in 259 acromegalic patients. When growth hormone was measured simultaneously, no correlation was found between serum growth hormone and plasma GHRH concentrations, irrespective of whether the acromegalic patients were treated or not. A possible explanation for this finding might be the lack of a feedback regulation between plasma growth hormone and GHRH. Also, since growth hormone is secreted in a pulsatile fashion the interpretation of single growth hormone values can be difficult. IGF I, which correlates well with mean growth hormone production, may therefore represent a more valuable criterion for the assessment of activity and GHRH plasma levels in acromegalics. However, no study has yet been performed to elucidate the relationship between GHRH and IGF I in acromegaly. To examine this relationship we measured the concentration of plasma GHRH and IGF I in 18 treated patients with acromegaly (age range 32-64 years median 50.5 years; median follow-up 6.5 years, range 3 months to 33 years). All immunoreactive GHRH levels were within the limits described as normal in the literature (mean +/- SD 22.89 +/- 2.72 pg/ml, range 19-28 pg/ml). The IGFI level was 396.78 +/- 224.26 ng/ml (mean +/- SD, range 71-876 ng/ml; reference ranges, age group 25-39 years: 114-492 ng/ml; 40-54 years: 90-360 ng/ml; > 55 years: 71-290 ng/ml). We found no correlation between IGF I and GHRH concentrations (r = 0.17). We therefore conclude that measuring plasma GHRH is not useful in the evaluation of the activity or therapy of acromegaly but may be helpful in its differential diagnosis since a massive elevation of GHRH is typically associated with the ectopic GHRH syndrome, a rare cause of acromegaly.